Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	14.14	34.97	30.64
Graham Fair Price	8.67	20.81	19.15
PEG	154.51	0.80	-0.31
Price/Book	-0.43	0.93	0.93
Price/Cash Flow	348.04	106.42	23.75
Prices/Earnings	-11.92	12.03	13.66
Price/Sales	7.22	4.43	4.13
Price/FCF	348.04	106.42	23.75
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-3.41	0.48	0.50
Operating Margin	-4.87	0.19	0.20
ROA	11.63	< 0.005	< 0.005
ROE	0.02	0.02	13.05
ROIC	0.02	0.01	-23.74
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.03	96.14
Dividends QOQ	0.13	-1.00	679.77
EBIT QOQ	-0.14	-0.10	26.88
EPS QOQ	-0.44	0.15	-65.39
FCF QOQ	0.54	-0.77	42.61
Revenue QOQ	< 0.005	-0.06	635.67
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	27.89	25.56	-8.35
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.52	0.52	-0.89
Quick Ratio	0.26	0.30	13.32
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	30.95	31.63	2.21
Cash	0.93	1.50	60.52
Capex	-0.40	-0.53	-34.45
Free Cash Flow	1.21	0.28	-77.28
Revenue	6.97	6.61	-5.08
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.35	0.31	-11.81
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	16.36	18.69	14.21
Naive Interpretation	Member

06 - Financial Health · Bad

Rating